View Clinical Trial (Medical Research Study)

A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee - NCT00565812-62704(Clinical Trial 109600)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Springfield
State:  
IL
Zip Code: 62704
Conditions: Osteoarthritis
Purpose: The objective of this 2-year study is to evaluate the safety, tolerability and disease modifying efficacy of SD 6010, an inhibitor of inducible nitric oxide synthase (iNOS), in overweight and obese subjects with knee osteoarthritis. The efficacy of SD-6010 will be evaluated by radiography using joint space narrowing in the medial tibiofemoral compartment of the study knee as the primary endpoint.
Study summary:
Criteria: Inclusion Criteria: - Subjects aged >= 40 years with a BMI >= 25 and <= 40 kg/m2 - In the past, has been diagnosed with knee OA - Radiographic evidence of OA in the study knee Exclusion Criteria: - A diagnosis of any other rheumatic disease - Current conditions in the study knee that would confound efficacy - Selected, traditional clinical safety and laboratory parameters
Study is available at: Pfizer Investigational Site
Springfield, IL 62704
United States

Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.